About SkinMedica
SkinMedica is a company based in Carlsbad (United States) founded in 1999 by Mitchel Goldman and Richard Fitzpatrick was acquired by Allergan in November 2012.. SkinMedica has raised $94.24 million across 5 funding rounds from investors including Apax Partners, Allergan and Split Rock Partners. SkinMedica has completed 1 acquisition, including Colorescience. SkinMedica operates in a competitive market with competitors including Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others.
- Headquarter Carlsbad, United States
- Founders Mitchel Goldman, Richard Fitzpatrick
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Skinmedica, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$94.24 M (USD)
in 5 rounds
-
Latest Funding Round
$9.44 M (USD), Series E
Jun 12, 2009
-
Investors
Apax Partners
& 8 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Allergan
(Nov 16, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of SkinMedica
SkinMedica has successfully raised a total of $94.24M across 5 strategic funding rounds. The most recent funding activity was a Series E round of $9.44 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series E — $9.4M
-
First Round
First Round
(04 Dec 2002)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2009 | Amount | Series E - SkinMedica | Valuation |
investors |
|
| Apr, 2005 | Amount | Series E - SkinMedica | Valuation |
investors |
|
| Jul, 2004 | Amount | Series D - SkinMedica | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SkinMedica
SkinMedica has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Apax Partners, Allergan and Split Rock Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US venture capital investments are made across all stages.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SkinMedica
SkinMedica has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Colorescience. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mineral-based sunscreens and clinical skincare products are developed.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SkinMedica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Skinmedica Comparisons
Competitors of SkinMedica
SkinMedica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
|
|
| domain | founded_year | HQ Location |
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics in aesthetics are developed, including botulinum toxin products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Skinmedica
Frequently Asked Questions about SkinMedica
When was SkinMedica founded?
SkinMedica was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Where is SkinMedica located?
SkinMedica is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Is SkinMedica a funded company?
SkinMedica is a funded company, having raised a total of $94.24M across 5 funding rounds to date. The company's 1st funding round was a Series D of $55.8M, raised on Dec 04, 2002.
What does SkinMedica do?
SkinMedica is a company that focuses on developing and commercializing products that improve skin appearance. They market and sell to physicians both prescription and non-prescription skin care products. Their line of aesthetic skin care products includes the TNS Essential Serum and hallmark TNS Recovery Complex. Their prescription product, VANIQA (eflornithine hydrochloride) Cream 13.9, is FDA-approved and reduces the growth of unwanted facial hair in women. Acquired by Allergen, a healthcare company in 2013 which was in turn acquired by Pfizer. Colorescience, a manufacturer of mineral makeup products, is a former division of SkinMedica, Inc.
Who are the top competitors of SkinMedica?
SkinMedica's top competitors include Revance Therapeutics, Dermavant and Bausch Health.
How many acquisitions has SkinMedica made?
SkinMedica has made 1 acquisition, including Colorescience.
Who are SkinMedica's investors?
SkinMedica has 9 investors. Key investors include Apax Partners, Allergan, Split Rock Partners, unknown, and EuclidSR Partners.